Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both? Source: Eur Respir J 2015; 46: 1551-1553 Year: 2015
Pulmonary embolism risk stratification: where are we heading? Source: Eur Respir J 2014; 43: 298-300 Year: 2004
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006
Fatal pulmonary embolism in young people: risk factors and clinical presentation Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009
Original, simplified, and modified pulmonary embolism severity indices in risk stratification of pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Pulmonary embolism and the consequences for the right heart Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136 Year: 2006
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene Source: Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019 Year: 2020
Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009
Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018
Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016 Year: 2017
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020
Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020